Cadrenal Therapeutics, Inc.
CVKD
$1.19
-$0.01-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.39M | 2.31M | 4.01M | 3.86M | 5.57M |
| Total Receivables | 2.69M | 5.50K | 5.10K | 12.80K | 19.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 410.10K | 428.10K | 200.10K | 116.00K | 358.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 95.70K | 113.60K | 106.30K | 90.80K | 23.90K |
| Total Current Assets | 5.58M | 2.86M | 4.32M | 4.08M | 5.97M |
|
|
|||||
| Total Current Assets | 5.58M | 2.86M | 4.32M | 4.08M | 5.97M |
| Net Property, Plant & Equipment | 2.70K | 4.60K | 5.20K | 5.70K | 4.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.20K | 2.20K | 2.20K | 2.20K | 2.20K |
| Total Assets | 5.59M | 2.86M | 4.33M | 4.09M | 5.98M |
|
|
|||||
| Total Accounts Payable | 871.90K | 824.80K | 650.70K | 614.10K | 895.60K |
| Total Accrued Expenses | 625.30K | 240.10K | 937.30K | 738.50K | 783.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.50M | 1.07M | 1.59M | 1.35M | 1.68M |
|
|
|||||
| Total Current Liabilities | 1.50M | 1.07M | 1.59M | 1.35M | 1.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.50M | 1.07M | 1.59M | 1.35M | 1.68M |
|
|
|||||
| Common Stock & APIC | 48.87M | 43.25M | 41.70M | 38.66M | 37.53M |
| Retained Earnings | -44.78M | -41.46M | -38.96M | -35.92M | -33.24M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.09M | 1.80M | 2.74M | 2.73M | 4.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.09M | 1.80M | 2.74M | 2.73M | 4.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.09M | 1.80M | 2.74M | 2.73M | 4.30M |
|
|
|||||